A Validated NMR Approach for MDMA Quantification in Ecstasy Tablets

被引:20
|
作者
Almeida, Nathalia S. [1 ]
Benedito, Luiz E. C. [1 ]
Maldaner, Adriano O. [2 ]
de Oliveira, Aline L. [1 ]
机构
[1] Univ Brasilia, Inst Quim, BR-70910900 Brasilia, DF, Brazil
[2] Policia Fed, Inst Nacl Criminalist, SAIS Quadra 07 Lote 23, BR-70610200 Brasilia, DF, Brazil
关键词
ecstasy; MDMA; qNMR; forensic analysis; validation; SPECTROSCOPY;
D O I
10.21577/0103-5053.20180071
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In recent years, ecstasy trafficking has grown in complexity and tablets has been commonly sold containing different contents of 3,4-methylenedioxymethamphetamine (MDMA) or even other psychoactive substances. In contrast, identification and quantification of drugs of abuse is still a challenge, once the access to drug standards is very restricted in Brazil. In this work, ecstasy tablets seized by the Brazilian Federal Police have their chemical composition identified and quantified by gas chromatography and quantitative H-1 nuclear magnetic resonance based on an internal standard approach (IS-H-1-qNMR). Both methods were validated and showed suitable results for the figures of merit. IS-H-1-qNMR shows excellent results of accuracy (relative error < 5%) and precision (relative standard deviation (RSD) < 2%). Comparatively, IS-H-1-qNMR is more efficient and versatile than gas chromatography to accomplish in a single analysis the identification and quantification of target analytes. Since the method does not require a specific reference material, it is cost effective and provides agility to routine forensic analysis.
引用
收藏
页码:1944 / 1950
页数:7
相关论文
共 50 条
  • [11] Neuropsychiatric disorders induced by MDMA ("ecstasy")
    Bailly, D
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 1999, 25 (06): : 595 - 602
  • [12] Methylenedioxymethamphetamine (MDMA, "Ecstasy")
    Shannon, M
    PEDIATRIC EMERGENCY CARE, 2000, 16 (05) : 377 - 380
  • [13] Psychological aspects of MDMA (ecstasy) consummers
    Varescon, I
    ANNALES DE MEDECINE INTERNE, 2003, 154 : S81 - S85
  • [14] The current aspects of the use of ecstasy/MDMA in France
    Spadari, Michel
    Batisse, Anne
    Guerlais, Marylene
    Boucher, Alexandra
    Daveluy, Amelie
    Le Boisselier, Reynald
    Gibaja, Valerie
    Eiden, Celine
    Lepelley, Marion
    Roussin, Anne
    Deheul, Sylvie
    Frauger, Elisabeth
    Debruyne, Daniele
    THERAPIE, 2016, 71 (06): : 553 - 562
  • [15] Prospective memory impairment in “ecstasy” (MDMA) users
    Peter G. Rendell
    Timothy J. Gray
    Julie D. Henry
    Anne Tolan
    Psychopharmacology, 2007, 194 : 497 - 504
  • [16] THE EMERGENCE OF MDMA: SUPER STRENGTH ECSTASY PILLS
    de la Fuente, D.
    Tejedor, E.
    Cuesta, M. J.
    Pantiga, J.
    Moro, J.
    Rodriguez, L.
    Colinas, V
    Lumbreras, V
    Miralles, M.
    Fernandez, A.
    Plaza, A.
    Deza, A.
    Gonzalez, A.
    Zazo, R.
    Benedi, J.
    Tejedor, J. M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2018, 123 : 84 - 84
  • [17] Chronic MDMA (ecstasy) use, cognition and mood
    McCardle, K
    Luebbers, S
    Carter, JD
    Croft, RJ
    Stough, C
    PSYCHOPHARMACOLOGY, 2004, 173 (3-4) : 434 - 439
  • [18] A review of the acute subjective effects of MDMA/ecstasy
    Baylen, Chelsea A.
    Rosenberg, Harold
    ADDICTION, 2006, 101 (07) : 933 - 947
  • [19] Prospective memory impairment in "ecstasy" (MDMA) users
    Rendell, Peter G.
    Gray, Timothy J.
    Henry, Julie D.
    Tolan, Anne
    PSYCHOPHARMACOLOGY, 2007, 194 (04) : 497 - 504
  • [20] ON THE ANALYSIS OF MDMA (ECSTASY, ADAM) AND MDEA (EVE)
    ROP, PP
    GRIMALDI, F
    SALMON, T
    CONTI, M
    PONSONNAILLE, C
    VIALA, A
    ANALUSIS, 1995, 23 (01) : 1 - 6